Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M F Prummel

Showing results (51-60 of 66) with videos related to

Pageof 7
Sort By:
The Netherlands Journal of Medicine|November 24, 1998
Establishment of reference values for endocrine tests. I: Cushing's syndromeM J de Bos Kuil, E Endert, E Fliers, et al.
Clinical Endocrinology|March 16, 2000
Association of thyrotrophin receptor antibodies with the clinical features of Graves' ophthalmopathyM N Gerding, J W van der Meer, M Broenink, et al.
The Netherlands Journal of Medicine|September 4, 1999
Establishment of reference values for endocrine tests. II: HyperprolactinemiaR Le Moli, E Endert, E Fliers, et al.
Nederlands Tijdschrift Voor Geneeskunde|May 27, 2004
[Subclinical hypothyroidism; the start of a clinical trial into the usefulness of treatment with radioactive iodine]E H Hoogendoorn, W M Wiersinga, M F Prummel, et al.
Clinical Endocrinology|January 27, 2005
Measuring disease activity to predict therapeutic outcome in Graves' ophthalmopathyC B Terwee, M F Prummel, M N Gerding, et al.
Ophthalmology|April 1, 1993
A new ultrasonographic method to detect disease activity and predict response to immunosuppressive treatment in Graves ophthalmopathyM F Prummel, M S Suttorp-Schulten, W M Wiersinga, et al.
Clinical Endocrinology|August 25, 2005
Surgical or medical decompression as a first-line treatment of optic neuropathy in Graves' ophthalmopathy? A randomized controlled trialI M M J Wakelkamp, L Baldeschi, P Saeed, et al.
Clinical and Experimental Immunology|March 6, 2002
Smoking and disease severity are independent determinants of serum adhesion molecule levels in Graves' ophthalmopathyI M M J Wakelkamp, M N Gerding, J W C van der Meer, et al.
The New England Journal of Medicine|November 16, 1989
Prednisone and cyclosporine in the treatment of severe Graves' ophthalmopathyM F Prummel, M P Mourits, A Berghout, et al.
Journal of Clinical Epidemiology|October 21, 1999
Test-retest reliability of the GO-QOL: a disease-specific quality of life questionnaire for patients with Graves' ophthalmopathyC B Terwee, M N Gerding, F W Dekker, et al.
Pageof 7

Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
The Netherlands Journal of Medicine|November 24, 1998
Establishment of reference values for endocrine tests. I: Cushing's syndromeM J de Bos Kuil, E Endert, E Fliers, et al.
Clinical Endocrinology|March 16, 2000
Association of thyrotrophin receptor antibodies with the clinical features of Graves' ophthalmopathyM N Gerding, J W van der Meer, M Broenink, et al.
The Netherlands Journal of Medicine|September 4, 1999
Establishment of reference values for endocrine tests. II: HyperprolactinemiaR Le Moli, E Endert, E Fliers, et al.
Nederlands Tijdschrift Voor Geneeskunde|May 27, 2004
[Subclinical hypothyroidism; the start of a clinical trial into the usefulness of treatment with radioactive iodine]E H Hoogendoorn, W M Wiersinga, M F Prummel, et al.
Clinical Endocrinology|January 27, 2005
Measuring disease activity to predict therapeutic outcome in Graves' ophthalmopathyC B Terwee, M F Prummel, M N Gerding, et al.
Ophthalmology|April 1, 1993
A new ultrasonographic method to detect disease activity and predict response to immunosuppressive treatment in Graves ophthalmopathyM F Prummel, M S Suttorp-Schulten, W M Wiersinga, et al.
Clinical Endocrinology|August 25, 2005
Surgical or medical decompression as a first-line treatment of optic neuropathy in Graves' ophthalmopathy? A randomized controlled trialI M M J Wakelkamp, L Baldeschi, P Saeed, et al.
Clinical and Experimental Immunology|March 6, 2002
Smoking and disease severity are independent determinants of serum adhesion molecule levels in Graves' ophthalmopathyI M M J Wakelkamp, M N Gerding, J W C van der Meer, et al.
The New England Journal of Medicine|November 16, 1989
Prednisone and cyclosporine in the treatment of severe Graves' ophthalmopathyM F Prummel, M P Mourits, A Berghout, et al.
Journal of Clinical Epidemiology|October 21, 1999
Test-retest reliability of the GO-QOL: a disease-specific quality of life questionnaire for patients with Graves' ophthalmopathyC B Terwee, M N Gerding, F W Dekker, et al.
Pageof 7